BEAM
Beam Therapeutics Inc
NASDAQ: BEAM · HEALTHCARE · BIOTECHNOLOGY
$29.38
-3.86% today
Updated 2026-04-29
Market cap
$3.02B
P/E ratio
—
P/S ratio
21.60x
EPS (TTM)
$-0.81
Dividend yield
—
52W range
$15 – $36
Volume
2.1M
Beam Therapeutics Inc (BEAM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-57.20%
Operating margin
-15.30%
ROE
-8.11%
ROA
-18.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-8.73M | — | — | — |
| 2018 | $0.00 | $-115.26M | — | — | — |
| 2019 | $18000.00 | $-78.33M | -303,338.89% | -417,522.22% | -435,144.44% |
| 2020 | $24000.00 | $-194.59M | -429,812.50% | -553,166.66% | -810,800.00% |
| 2021 | $51.84M | $-370.64M | -347.75% | -757.01% | -714.91% |
| 2022 | $60.92M | $-289.09M | -411.48% | -555.61% | -474.54% |
| 2023 | $377.71M | $-132.53M | 100.00% | -46.73% | -35.09% |
| 2024 | $63.52M | $-376.74M | -478.67% | -654.25% | -593.13% |
| 2025 | $139.74M | $-79.99M | 84.05% | -274.57% | -57.24% |